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Abstract
Negative-pressure wound therapy, commercially known as vacuum-assisted closure (V.A.C.
®) therapy, has become
one of the most popular (and efficacious) interim (prior to flap reconstruction) or definite methods of managing
deep sternal wound infection. Complications such as profuse bleeding, which may occur during negative-pressure
therapy but not necessarily due to it, are often attributed to a single factor and reported as such. However, despite
the wealth of clinical experience internationally available, information regarding certain simple considerations is still
lacking. Garnering information on all the factors that could possibly influence the outcome has become more
difficult due to a (fortunate) decrease in the incidence of deep sternal wound infection. If more insight is to be
gained from fewer clinical cases, then various potentially confounding factors should be fully disclosed before
complications can be attributed to the technique itself or improvements to negative-pressure wound therapy for
deep sternal wound infection can be accepted as evidence-based and the guidelines for its use adapted. The
authors propose the adoption of a simple checklist in such cases.
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Serious bleeding during topical negative-pressure wound
therapy (NPWT), commercially known as vacuum-
assisted closure (V.A.C.
®) therapy, for deep sternal
wound infection (DSWI), is exceedingly rare.
The source of the bleeding is either from the right ven-
tricle (RV) [1-4] or a vessel (aorta or homograft, or coron-
ary bypass graft). Two mechanisms have been linked to
serious bleeding and NPWT therapy: infectious erosion
[5,6] or, in the case of the RV, a combination of mechanics
(displacement of the heart towards or in between the
sternal edges [7] and fibrous adherence of the RV to the
sternum [1]).
To these two mechanisms Kiessling and colleagues [8]
add, in the most recent volume of the Journal, penetration
by dislodged bone and/or wire fragments as a cause of
severe bleeding. Clearly, neither penetration due to dislod-
gement nor erosion due to incomplete infection control
are caused by but may occur during negative-pressure
therapy.
Does negative- pressure, however unequivocally, contri-
bute to an increased risk of critical bleeding? A number
of arguments can be put forward against this proposition:
1. Critical bleeding during the “open” (dressing) man-
agement of DSWI, prior to the introduction of NPWT,
has been rare [9] yet is well known. Interestingly, the
pathogenesis suggested and lucidly described by Robic-
sek [10] in 1997 is not different from that currently
associated with NPWT.
2. Whereas internationally NPWT has become one of
the most popular (and efficacious) interim (prior to flap
reconstruction) or definite methods of managing DSWI,
the total number of exsanguinations reported is rarer still.
In the last 5 years (2005-2010), the incidence of bleeding
during NPWT for DSWI in the Academic Medical Center,
Amsterdam was 3.4% (2 from 58). One was a minor bleed-
ing from the RV, which was stopped with a single stitch,
on the ward; the other was major from an infected aorta,
which had to be taken back to theatre. The incidence at
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3. Interface dressings offer dual, mechanical protection:
firstly, the RV is protected from both adherence to and
friction from the raw sternal edges. Secondly, interface
dressings always result in a loss of negative pressure
underneath the dressing, as was demonstrated by the fre-
quently overlooked study of Jones and colleagues [11].
The degree of loss depends on the type of interface dres-
sing used. The highest mean decrease in pressure occurred
with the use of paraffin-impregnated gauze [11].
Polyamide nets, impregnated with silicone jell interface
dressing (e.g. Mepitel
®) resulted in the smallest decrease
in mean pressure. (Mepitel
® is thus a silicone, not a paraf-
fin/petrolatum, dressing - this distinction is important
because of the differing reactions of the diverse coating
materials to body temperature). Either paraffin-impreg-
nated gauze (e.g. Jelonet
®) or cellulose, acetate fibre coated
with a petrolatum emulsion (e.g. Adaptic
®)i st h em o s t
common type of interface dressing used worldwide during
NPWT therapy for DSWI. The elegant studies of Petzina
and colleagues [12] supported these findings, observing a
53 ± 5 mmHg pressure difference between precardiac
space and vacuum source when 4 layers of paraffin-
impregnated gauze were interposed. Thus, although more
clinical studies are required, negative pressure between the
layers of protective gauze and the heart is considerably
less than generally suspected. If neither the use of or pre-
ference for an interface dressing is mentioned in a study,
one could be tempted to underestimate its significance.
The highly respected and productive group from Lund,
Sweden, would perhaps counter that an interface dressing
may not prevent displacement and bulging of the RV into
the diastasis between the sternal edges during NPWT.
Malmsjö and colleagues [7] base their argument on an
MRI animal study. In their (small) study group the bulging
was seen in only 2 of 6 animals. Was the displacement a
prelude to rupture? Would the bulging not eventually
have occurred in certain cases, in any way? Robicsek [10]
believed that RV rupture results from the sudden impact
(not continuous) of the RV, in the exposed mediastinum,
being squeezed against the restraining edges of the
sternum by pressures in the lung and pleural cavities
exceeding 300 - 600 mmHg when the patient coughs or
struggles. Nevertheless, following their line of thought,
Lindstedt and colleagues [13], in the same volume of the
Journal, present a novel solution to prevent the bulging,
which they attribute to NPWT: a rigid disk. Though the
idea is applaudable, it may not be sufficient.
During NPWT, bacterial load may, contrary to popular
belief, remain quantitatively unchanged or increase una-
bated [14,15], thereby increasing the risk of infectious
erosion. A significant (p < 0.05) quantitative increase in
Staphylococcus aureus, the most common pathogen
found in postoperative mediastinitis, was observed in the
elegant clinical NPWT- study by Mouës and colleagues
[16]. The replication behaviour of coagulase-negative
staphylococci (CoNS), which are ever more frequently
encountered culprits in cases with DSWI, was not
reported. Incidentally, in 2 of the 3 reports [3,5,8] of ser-
ious bleeding during NPWT for DSWI, the cultures were
CoNS positive. In older publications, the associated
microorganisms were seldom mentioned. It is of interest
that none of the animals studied by the Lund group were,
for obvious ethical reasons, infected (and, as far as we
could ascertain, none developed bleeding).
Progress of infection will not only increase the risk of
serious bleeding [17], but may also result in the unneces-
sary prolongation and ultimate failure of NPWT [3,18].
This may manifest itself in one of two ways: failure of the
progress of healing or as recurrent sternal infection (RSI).
Bapat and colleagues [3] found that two-thirds of the
patients requiring readmission for further surgery for RSI
had been on NPWT as treatment for DSWI for longer
than 21 days. Their observation was supported by another
recent study [18] where a significant difference (p=
0.0145) was shown to exist in the mean time of NPWT
prior to sternal osteosynthesis between those patients who
developed RSI and those who did not.
The unfortunate, common denominator in all these
reports is the relatively small numbers of patients. If we
are to base the association, if any, between NPWT and
severe bleeding on evidence and further our knowledge of
the mechanism, it will require a meta-analysis. If more
insight is to be gained from fewer clinical cases treated by
NPWT, then various potentially confounding factors
should be disclosed. The garnering of sufficient informa-
tion for a meta-analysis will only succeed if all possible
determinants are not only recorded, but also assiduously
reported. Despite the wealth of clinical experience interna-
tionally available, information regarding certain simple
considerations is still lacking. These considerations include
whether the pressure should be adjusted or the choice of
interface altered in certain situations, whether it is only
once the right ventricle becomes infected that the risk of
rupture increases, whether the complication is purely
mechanical, how progress in wound healing is measured,
and whether the therapy be stopped after a period of time.
For this reason, we propose that those interested in the
field (authors and editors alike) make use of a simple
checklist prior to the submission of their manuscripts. The
checklist should include, at least: the microorganisms
involved, the interface dressing used, the negative pressure
setting(s), the frequency of changes of dressing and the
total period of NPWT (Table 1). Additional factors worth
considering inclusion would be: type of anticoagulation
used during treatment, site of CABG- graft to the right
coronary artery (if performed), right heart failure, level of
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lation, dialysis, etc), extent of debridement performed (pre-
sence of wires or bone spicula, etc).
In conclusion, it is undeniable that NPWT has become a
valued method and has often simplified the management
of DSWI [19]. Recommendations to prevent complications
and improve the efficacy of NPWT are commendable.
Nevertheless, we feel that large-scale clinical observational
studies making available all the information suggested in
Table 1 are essential to establish whether a complication
can be attributed to the technique. This would allow the
guidelines for its use to be adapted and also for further
improvements to NPWT for DSWI.
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